Folfirinox vs. Gemcitabine + Nab-Paclitaxel as the First-Line Treatment for Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Nooraldin MerzaSabeeh Khawar FarooquiSophia Haroon DarTony VarugheseRehmat Ullah AwanLamaan QureshiSaad Ali AnsariHadi QureshiJamie McilvaineIshaan VohraYusuf NawrasAbdallah KobeissyMona HassanPublished in: World journal of oncology (2023)
FFX and GnP showed a significant difference in increasing the PFS, while no difference was observed while measuring OS. Safety outcomes showed that FFX and GnP shared similar safety profiles as FFX was associated with hematological outcomes, while GnP was more associated with non-hematological outcomes.